South Carolina Showcases Innovations in Life Sciences at BIO International in San Diego

South Carolina Showcases Innovations in Life Sciences at BIO International

From June 22 to 25, 2026, San Diego will become the hub for life science innovation as South Carolina, represented by SCbio, takes center stage at the BIO International convention. This event, hosted by the Biotechnology Innovation Organization, will highlight the impressive growth and economic impact of South Carolina's life sciences sector, which contributes approximately $20.1 billion annually.

SCbio, the primary organization unifying life sciences efforts in the state, will showcase 15 renowned companies and organizations deeply rooted in South Carolina’s vibrant ecosystem. The initiative underscores the state's commitment to fostering collaboration and driving innovation across the biotech and medtech landscapes.

The South Carolina life sciences sector has gained significant momentum and is now recognized as one of the fastest-growing hubs in the Southeastern United States. With a workforce of over 63,000 professionals and more than 1,000 life sciences firms operating in the area, South Carolina is poised to make a lasting impact on the national and global stage.

James Chappell, Ph. D., President and CEO of SCbio, emphasized that South Carolina is arriving at BIO 2026 with palpable momentum and a clear focus on innovation. He stated, "Our ecosystem has matured enough to attract research-driven entities while being flexible to support their growth. This strategic positioning is transforming South Carolina into a nationally recognized leader in life sciences."

The presence of SCbio at BIO 2026 offers a pivotal opportunity to connect with global industry leaders, promote various investment possibilities, and showcase the talent and infrastructure that are propelling growth throughout South Carolina's life sciences landscape. The state's commitment to innovation was further highlighted in 2024, when the South Carolina Department of Commerce recognized the life sciences industry as one of its top three priorities for economic growth.

Among the notable companies participating alongside SCbio at this year’s BIO convention are leading diagnostic information services provider Quest Diagnostics, biopharmaceutical manufacturing giant AmbioPharm, and various economic development partners such as the South Carolina Department of Commerce.

Attendees can find the South Carolina pavilion at booth #2121, where SCbio will host numerous events, meetings, and networking opportunities designed to foster strategic partnerships and amplify the state's capabilities in pharmaceuticals, biotechnology, medical devices, and digital health sectors.

As the life sciences industry continues to flourish in South Carolina, SCbio remains dedicated to accelerating growth and advocating for scientific advancements that have a positive impact on humanity. They are honoring a member-driven approach that unites startups, academia, government, and established enterprises in their mission.

For further details about SCbio and the life sciences industry, or to schedule a meeting during BIO 2026, potential contacts can reach out via their website at scbio.org or by contacting Connor Watkins, the director of marketing, at [email protected].

In conclusion, the showcase at BIO 2026 is not merely an exhibition but a testament to the innovative spirit and forward-thinking mindset of South Carolina’s life sciences sector, reinforcing its essential role in the global biotechnology narrative.